Your Cart

Free worldwide shipping on all orders over $50.00

Frequently asked Questions

Semaglutide (Ozempic) is an injectable drug that, when combined with diet and exercise, improves blood sugar management in type 2 diabetics. Semaglutide works in your body to reduce blood sugar levels after a meal by mimicking the hormone GLP-1. According to recent research, this medicine may also help with weight reduction.

Glucagon-like peptide 1 (GLP-1) is a hormone that has a large impact on blood sugar regulation by stimulating glucose-dependent insulin secretion. Insulin is a hormone that promotes sugar use by cells and signals the body to build skeletal muscle. Furthermore, GLP-1 slows gastric emptying (makes you feel full) and decreases the desire for food intake (because you feel full).

No, Semaglutide is not a type of insulin or a substitute for insulin. Semaglutide relies upon your body’s own insulin to create weight loss.

Semaglutide, on the other hand, is not a stimulant. While other weight reduction drugs, such as phentermine, have stimulating effects that suppress your hunger, Semaglutide works in a different way by promoting natural and healthy bodily processes.

GLP-1 agonists, such as Semaglutide, assist to manage blood sugar and help patients lose weight. GLP-1, the major hormone involved, reduces the rate at which your stomach empties food and the rate at which your pancreas and liver utilize insulin, causing you to feel less hungry, eat less, and lose more weight.

Semaglutide is currently only FDA-approved to aid with blood sugar management in type 2 diabetes and to reduce the risk of significant cardiovascular events (such as heart attack and stroke) in persons who have both type 2 diabetes and heart disease.

If you’re using Semaglutide for any of these reasons, you’ll take it exactly as prescribed by your doctor since you’re managing a chronic disease.

However, if you do not have type 2 diabetes and want to take Semaglutide to lose weight, we will have a better sense of long-term safety after the FDA examines data for this additional indication.

What we do know is that research participants got therapy for 68 weeks (approximately 1.5 years) throughout each of the company’s four studies.

There are a number of reasons that Ozempic® could be right for you if you have type 2 diabetes and you’re struggling to lower your blood sugar and reach your A1C goal.

Ozempic® injection 0.5 mg, 1 mg, 2 mg is an injectable prescription drug intended to enhance blood sugar (glucose) levels in persons with type 2 diabetes in conjunction with diet and exercise. In individuals with type 2 diabetes and established heart disease, it also reduces the risk of serious cardiovascular events such as stroke, heart attack, or death.

No, even if the needle is replaced, do not share your Ozempic® pen with others. You might either give or get a dangerous illness from other individuals.

You should always follow your doctor’s instructions and use your Ozempic® pen as directed.

Social media may help educate people about type 2 diabetes and how to manage it. It is crucial to note, however, that not every information regarding a drug or ailment on social media is true or reputable. If you have any concerns regarding Ozempic® or your treatment plan, you should consult with your doctor. Never alter your medication or treatment plan without first visiting your doctor.

Any material provided or sponsored by Novo Nordisk on the internet is properly labeled.

Ozempic®, coupled with diet and exercise, is authorized by the FDA for individuals with type 2 diabetes to decrease blood sugar and minimize the risk of serious cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes and known heart disease. People react differently to medications. That is why it is important to discuss any concerns you have about your treatment plan with your doctor.

Semaglutide is a GLP-1 receptor agonist, which mimics the activity of a hormone in the body called glucagon-like peptide-1 (GLP-1). In reaction to a meal, this hormone is produced from the stomach and instructs the body to create insulin, which helps to lower blood sugar levels.

Semaglutide decreases hunger, delays stomach emptying, and promotes feelings of fullness via binding to GLP-1 receptors in the brain. This aids in weight reduction by reducing food consumption.

Semaglutide is prescribed for people with a BMI of 30 or higher, or for adults with a BMI of 27 or higher who have at least one weight-related disorder such as high blood pressure, type 2 diabetes, or high cholesterol.

It’s crucial to remember that Semaglutide isn’t a miracle cure and should be taken in combination with a healthy diet and regular exercise for the greatest outcomes. It is also not advised for pregnant or nursing women, as well as those with a personal or family history of medullary thyroid cancer.

Semaglutide is administered as a once-weekly, self-administered, subcutaneous injection (under the skin). The starting dosage is 0.25 mg per week for four weeks, then increased to 0.5 mg per week for another four weeks. The maintenance dose is 1.0 mg per week.

It’s important to follow the prescribed dosing schedule and not to change the dose without consulting your healthcare provider.

Nausea, diarrhea, vomiting, and constipation are common adverse effects. These side effects normally improve with time and may be controlled with dietary adjustments, lots of water, and, if required, over-the-counter drugs.

Pancreatitis, gallbladder problems, an increased risk of thyroid cancer, and allergic responses are more significant but uncommon adverse effects. While using Semaglutide, your doctor should keep an eye out for these adverse effects.

Semaglutide has been found in clinical studies to be beneficial in aiding weight reduction. Over the course of a year, participants in a research published in the New England Journal of Medicine lost an average of 15% of their body weight.

It is crucial to highlight, however, that Semaglutide is a novel medicine with uncertain long-term consequences. It is also not a replacement for a healthy lifestyle. Even after taking the medicine, it is important to maintain good diet and exercise habits.

No. Semaglutide is not a stimulant and does not build habits. Semaglutide may be used with an appetite suppressant like phentermine or phendimetrazine.

Yes, Semaglutide is thought to help reduce your appetite, however this does not apply to everyone. GLP-1 not only slows stomach emptying, making you feel fuller for longer, but it also plays a direct function in appetite regulation.

No. Semaglutide is not covered by insurance for persons who do not have type 2 diabetes. Fortunately, we can provide our compounded medicine at a very reasonable price.

Please be patient. Some individuals may not lose weight in the first 4-8 weeks. Everyone is unique. Some individuals do not lose weight unless they increase their dosage to 1.00mg or even 1.50mg. Do not raise the dosage before 4 weeks.

Do not raise the dosage before 4 weeks. To prevent undesirable side effects, the medicine should be titrated up every 4 weeks. It is critical to adhere to the specified dose regimen.

Absolutely. If you discover a dosage that works for you, stick with it. Just keep in mind that no dosage should be increased before 4 weeks.

If you miss a dosage and it has been 5-7 days after your injection’s due date, continue on your current dose.

If you miss a dosage and it’s been 8-13 days since your injection’s due date, go back to the prior dose to avoid unpleasant side effects.

If you have any prior adverse effects and want to avoid them in the future, you may cut your dosage to.25mg and titrate back up to the appropriate level every 4-5 weeks.

If you miss a dosage and it has been 14 days or more after your injection’s due date, start at.25mg and titrate back up to the target amount every 4 weeks.

Stomach flu symptoms include stomach cramps, vomiting, lack of appetite, diarrhea (which may be watery or bloody), low blood sugar, upset stomach, heartburn, burping, gas, bloating, nausea, vomiting, stomach pain, loss of appetite, diarrhea, and constipation. This is not an exhaustive list of possible adverse effects; more may arise. For medical advice on side effects not described above, please contact our physician.

The most well-known negative effects of semaglutide usage are gastrointestinal. While almost half of those on semaglutide experience minor nausea, vomiting, and constipation, it is nevertheless well tolerated by 95 percent of patients. These adverse effects frequently occur early in treatment but are usually temporary and seldom result in therapy termination. Call our office if you are experiencing constipation, nausea, or gastrointestinal side effects.

Yes. When taken as indicated, semaglutide is regarded safe and effective. However, safety does not imply that there are no hazards.

Semaglutide also comes with a boxed warning concerning thyroid C-cell tumors in rats (with uncertain risk in humans), and it should be avoided if you or your family have a history of certain thyroid malignancies. People with type 1 diabetes with a history of pancreatitis should not use semaglutide. People who are on other blood sugar-lowering drugs should not use semaglutide.

Semaglutide is not authorized for use by anybody under the age of 18.

If you notice swelling or a lump in your neck, difficulty swallowing, a hoarse voice, or shortness of breath, contact your doctor very once. If you have multiple endocrine neoplasia type 2 (tumors in your glands) or a personal or family history of medullary thyroid cancer, you should not take semaglutide.

What are the dangers of thyroid cancer when using semaglutide?

Semaglutide was used to treat thyroid tumors or thyroid cancer in animal experiments. It is unknown whether or not these effects would occur in humans.

Hypoglycemia (low blood sugar) might make you feel very hungry, disoriented, angry, or unsteady. Eat hard candies, crackers, raisins, or drink fruit juice or non-diet cola to alleviate hypoglycemia swiftly. Stress, sickness, surgery, exercise, alcohol usage, and meal skipping may all have an impact on blood sugar levels.

The majority of drugs do not interact with Semaglutide. Semaglutide may impede digestion and make it more difficult for your body to absorb any medications you take orally. Inform your doctor about any additional medications you are taking, notably insulin or diabetic medications such as dulaglutide, exenatide, liraglutide, Byetta, Trulicity, Victoza, and others. Use separate brands of semaglutide at the same time.

Most drugs do not interact with Semaglutide, however you should avoid taking any medication, including acetaminophen, one hour before your weekly Semaglutide injection.

Seek immediate medical treatment or call 1-800-222-1222 for Poison Help. An overdose may result in severe nausea, vomiting, and low blood sugar.

Get in touch with us


Contact Form Demo
Free Worldwide shipping

On all orders above $50

Easy 30 days returns

30 days money back guarantee

International Warranty

Offered in the country of usage

100% Secure Checkout

PayPal / MasterCard / Visa